Consensus Chromocell Therapeutics Corporation

Equities

CHRO

US1711261057

Delayed Nyse Other stock markets 17:59:40 27/06/2024 BST			5-day change	1st Jan Change
1.37 ^USD	+3.80%		-11.61%	0.00%

06-24	Chromocell Therapeutics Corporation(NYSEAM:CHRO) added to S&P TMI Index	CI
05-15	Chromocell Therapeutics Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Evolution of the average Target Price on Chromocell Therapeutics Corporation

Price target over the last 5 years

History of analyst recommendation changes

acc98ffc870d5b3615.8T8gUcGlyTxv6mTPTRA0IPiwtFlSWkJEbjm6ah22arg.pVcTBK7ug2kAiRakFSJ1ab3FgRNhLwghFF2NP0TZM9mEe01midKWbD6jKQ~e1f99a2fa2f021b9507cb06bddd6c8d1

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

1.32 USD

Average target price

8.5 USD

Spread / Average Target

+543.94%

High Price Target

8.5 USD

Spread / Highest target

+543.94%

Low Price Target

8.5 USD

Spread / Lowest Target

+543.94%

Consensus detail

Consensus revision (last 18 months)

Annual profits - Rate of surprise

Company calendar